CARBOMED CARBOMED: Intelligent Electrified Carbonylation Platform for Sustainable Flow Manufacturing
- Coordinator
- Technische Universitaet Wien, Austria
- Runs
- 1 January 2027 to 30 June 2028
- Status
- Running
- EU funding
- €150k
- Total cost
- —
- Partners
- 1 organisations in 1 countries
- Type
- European Research Council grant
- Grant agreement
- 101335052
What the project is doing
In the project's own words, from its summary on CORDIS.
CARBOMED aims to translate a breakthrough from the ERC Consolidator Grant CARBOFLOW into a modular, autonomous synthesis platform that integrates high-temperature CO2 electrolysis with continuous-flow carbonylation chemistry and real-time machine learning control. While the primary application field is pharmaceutical manufacturing, the underlying technology establishes a broadly applicable platform for electrified carbonylation processes across the chemical industry.
Amide bonds are among the most ubiquitous functional groups in fine chemicals and in active pharmaceutical ingredients (APIs), yet conventional synthesis routes remain environmentally and operationally inefficient, relying on stoichiometric coupling agents or hazardous, pressurized carbon monoxide. CARBOMED introduces a fully integrated, digitally augmented synthesis platform that electrochemically reduces CO2 to CO and immediately channels it into a closed-loop continuous-flow reactor.
This system is enhanced by a machine learning optimization engine that dynamically tunes process parameters - such as temperature, pressure, and residence time -based on real-time data from inline infrared spectroscopy. The PoC project will demonstrate the platform’s performance across three high profile drug-relevant amides and validate its robustness, selectivity, and sustainability. Technical activities include reactor integration, catalyst testing, ML-based optimization, and mid-scale operation under industrially relevant conditions.
The project de-risks the technology as a transferable platform suitable for pharmaceutical companies while offering clear expansion potential into wider carbonylation-based chemical production. Ultimately, CARBOMED offers a modular, scalable, and sustainable synthesis platform using carbon circularity and AI-guided automation, setting the stage for next-generation green chemistry applications.
Who is involved
| Organisation | City | Country | Role |
|---|---|---|---|
| Technische Universitaet Wien | Wien | Austria | Coordinator |
Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI